Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesCaffeine-potentiated chemotherapy for metastatic osteosarcoma
Journal of Orthopaedic Science, 10/06/09
Kimura H et al. – Caffeine–potentiated chemotherapy prolonged survival of patients who had osteosarcoma with pulmonary metastasis. Especially, patients with pulmonary metastasis identified after completion of treatment or with a solitary pulmonary nodule had good prognoses.
Related Articles
The role of interferons in the treatment of osteosarcoma
Pediatric Blood & Cancer, 11/12/09
Relevance Score: 88%
Reconstruction Using a Frozen Bone Method for Osteosarcoma of the Talus. A Case Report and Review of the Literature
Anticancer Research, 11/11/09
Relevance Score: 88%
Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways
British Journal of Cancer, 11/06/09
Relevance Score: 88%
Synchronous and metachronous skeletal osteosarcomas: The Norwegian Radium Hospital experience
Acta Oncologica, 10/26/09
Relevance Score: 88%
Tumoral Calcinosis Mimicking Recurrent Osteosarcoma
Radiology Case Reports, 10/23/09
Relevance Score: 88%
Today in Chemotherapy/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Triweekly Oxaliplatin Plus Oral Capecitabine as First-Line Chemotherapy in Elderly Patients With Advanced Gastric Cancer
American Journal of Clinical Oncology, 12/07/09
Gemcitabine and capecitabine in previously anthracycline-treated metastatic breast cancer: a multicenter phase II study (SOLTI 0301 trial)
Annals of Oncology, 12/07/09
Cetuximab administered once every second week to patients with metastatic colorectal cancer: a two-part pharmacokinetic/pharmacodynamic phase I dose-escalation study
Annals of Oncology, 12/07/09
Sponsor
Article Search
Sponsor